Skip to main content
OpenTrials
Completed

NCT Number: NCT05470660

Coronally Advanced Flap With Alloderm Versus Coronally Advanced Flap With Micro-needling on RT1 Gingival Recession

This study aims to assess the effect of micro-needling together with coronally advanced flap procedure on the gain of gingival thickness (GT) and keratinized tissue width (KTW) and compare it to Alloderm with coronally advanced flap procedure in the management of thin periodontal phenotype associated with recession type 1 (RT1)

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Dentistry - Cairo University

Cairo, Egypt

About this study

Gingival or periodontal diseases were found to occur more likely in patients with a thin gingival biotype. The periodontal phenotype was also found to show stronger correlation with gingival thickness rather than keratinized tissue width and papilla height. Moreover, the thin gingiva was usually found to be associated with thin bony plate with potential for dehiscence and fenestration and hence was thought to be at risk for recession after trauma.

Several techniques have been recommended for the treatment of gingival recession. One of the most predictable outcome is associated with the use of a coronally advanced flap and acellular dermal matrix graft.

Treatment of thin periodontal phenotype through the conjunction of i-PRF and micro-needling may be a first move of the non-surgical approach for improving the gingival thickness. Micro-needling was proved to be generally an effective and safe therapeutic option for numerous dermatologic conditions as clinical improvement of scars, striae, and rhytids with appropriate recovery and limited side effects. The controlled dermal wounding and stimulation of the wound healing cascade through Micro-needling was found to enhance collagen production and thus was responsible for the clinical results obtained.

Therefore, this study will be aiming to compare the effect of micro-needling on the gingival thickness in root coverage procedures. It will also provide an insight of its effect on the patient related factors and the root coverage parameters.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient consulting in the outpatient clinic.
  • Able to tolerate the study procedures.
  • Patient ready to perform oral hygiene instructions.
  • Compliance with the maintenance program.
  • Provide informed consent.
  • Accepts the 6 months follow-up period
  • Mature permanent tooth.
  • Full-mouth plaque index (PI) and full-mouth bleeding on probing (BOP) score of ≤ 15%.
  • Presence of identifiable Cemento-enamel Junction.
  • RT1 facial recession defect of ≥3 mm.
  • Clinical indication and/or patient request for recession coverage

Exclusion criteria

  • Medically compromised patients.
  • use of any drugs that might lead to gingival enlargement
  • Pregnant or nursing women.
  • Uncooperative patients.
  • Smokers.
  • Teeth with malocclusion, crowding, fillings, missing or supernumerary mandibular anterior teeth.
  • Cairo Recession Type 3 (RT3) recession defects.
  • Teeth with active orthodontic treatment.
  • Previous periodontal surgery.

Treatment and study plan

Root coverage using coronally advanced flap combined with micro-needling

Procedure

modified coronally advanced flap will be performed in sites of recession defects, then micro-needling will be performed after 1 month from the coronally advanced flap procedure to ensure the initial flap healing.

coronally advanced flap combined with Alloderm

Procedure

modified coronally advanced flap will be performed in sites of recession defects in Association with alloderm to cover the exposed root and 3 mm of connective tissue mesial and distal to it.

Primary outcomes

  1. Gingival thickness (GT) in mm

    Time frame: 6 months

    Gingival thickness (GT) will be specified at a mid-buccal location approximately 1 mm apical to the probing depth (PD) level with a #15 endodontic spreader. The reamer will be pierced, perpendicularly to the mucosal surface, through the soft tissue with light pressure until a hard surface is felt. The silicone disk stop will then be placed in tight contact with the soft tissue surface and fixed by a drop of cyanoacrylate adhesive; after careful removal of the reamer, penetration depth will be measured with a caliper to the nearest 0.1 mm gingival thickness changes will be calculated after 6 months

Secondary outcomes

  1. Keratinized tissue width (KTW) in mm

    Time frame: 6 months

    Keratinized tissue (KT) will be measured from the most apical point of the gingival margin to the mucogingival junction measurements will be recorded at baseline and after 6 months

  2. Clinical Attachment Level (CAL) in mm

    Time frame: 6 months

    Will be measured from the Cemento-enamel Junction to the bottom of the gingival sulcus at baseline and 6 months

  3. Gingival Recession Depth (RD) in mm

    Time frame: 6 months

    Will be measured from the Cemento-enamel Junction to the most apical extension of the gingival margin.

  4. Gingival Recession Width (RW) in mm

    Time frame: 6 months

    Will be measured horizontally between the borders of the recession at the level of Cemento-enamel Junction.

  5. Percentage of root coverage

    Time frame: 6 months

    Preoperative vertical recession - Postoperative vertical recession/preoperative vertical recession) x 100.

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

The Effect of Coronally Advanced Flap With Acellular Dermal Matrix (Alloderm) Versus Coronally Advanced Flap With Micro-needling on RT1 Gingival Recession: A Pilot Study

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jul 22, 2022
Registry last updated
Jul 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.